Go Pro

GRI Bio (GRI) Earnings Date, Estimates & Call Transcripts

GRI Bio logo
$1.91 -0.05 (-2.55%)
As of 04:00 PM Eastern

GRI Bio Earnings Summary

GRI Bio released Q2 2026 earnings on August 14, 2026, reporting an EPS of -$0.91, which topped analysts' consensus estimates of -$1.19 by $0.28. With a trailing EPS of -$38.37, GRI Bio's earnings are expected to grow next year, from ($4.77) to ($2.54) per share.

Upcoming Q3
Earnings Date
Nov. 13Before Market OpensEstimated
Consensus EPS
(Aug. 14)
-$1.19
Actual EPS
(Aug. 14)
-$0.91 Beat By $0.28

Q2 2026 Earnings Resources

GRI Upcoming Earnings

GRI Bio's next earnings date is estimated for Friday, November 13, 2026, based on past reporting schedules.

Get GRI Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GRI Bio and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

GRI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GRI Bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20262-$1.24-$1.15-$1.20
Q3 20262-$1.21-$0.95-$1.08
Q4 20262-$1.18-$0.96-$1.07
2026 6 -$3.63 -$3.06 -$3.35
Q1 20271-$1.25-$1.25-$1.25
Q2 20271-$1.22-$1.22-$1.22
Q3 20271-$1.19-$1.19-$1.19
Q4 20271-$1.16-$1.16-$1.16

GRI Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/13/2026
(Estimated)
--------
8/14/2026Q2 2026-$1.19-$0.91+$0.28-$0.91--
5/13/2026Q1 2026-$1.6050-$1.61 -$0.0050-$1.61--
1/30/2026Q4 2025-$23.52-$23.52--
11/14/2025Q3 2025-$31.08-$35.84 -$4.76-$1.28--
8/14/2025Q2 2025-$36.68-$36.68--$1.31--
5/15/2025Q1 2025-$114.24-$162.40 -$48.16-$5.80--

GRI Bio Earnings - Frequently Asked Questions

GRI Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 13th, 2026 based off last year's report dates. Learn more on GRI's earnings history.

In the previous quarter, GRI Bio (NASDAQ:GRI) reported ($0.91) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.19) by $0.28. Learn more on analysts' earnings estimate vs. GRI's actual earnings.

GRI Bio's earnings report can be found in their filing with the SEC.
View SEC filing

GRI Bio (NASDAQ:GRI) has a recorded net income of -$11.96 million. GRI has generated -$38.37 earnings per share over the last four quarters.

GRI Bio's earnings are expected to grow from ($4.77) per share to ($2.54) per share in the next year.


Earnings data for NASDAQ:GRI is sourced from Fiscal.ai, with the most recent quarter reported on 8/14/2026. New results are added as companies report their earnings.
From Our Partners